AstraZeneca PLC (LON: AZN)

AstraZeneca Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	45,811	44,351	37,417	26,617	24,384
Revenue Growth (YoY)	3.29%	18.53%	40.58%	9.16%	10.38%
Cost of Revenue	8,268	12,391	12,437	5,299	4,921
Gross Profit	37,543	31,960	24,980	21,318	19,463
Selling, General & Admin	18,222	18,955	15,680	11,693	11,848
Research & Development	10,935	9,762	9,736	5,991	5,958
Other Operating Expenses	0	-514	-1,492	-1,528	-1,541
Operating Expenses	28,821	28,203	23,924	16,156	16,265
Operating Income	8,193	3,757	1,056	5,162	2,924
Interest Income	301	95	43	87	172
Interest Expense	1,589	1,346	1,300	1,306	1,432
Other Expense / Income	12	10	67	-25	8
Pretax Income	6,899	2,501	-265	3,916	1,548
Income Tax	938	-792	-380	772	321
Net Income	5,955	3,288	112	3,196	1,335
Net Income Growth	81.11%	2835.71%	-96.50%	139.40%	-38.05%
Shares Outstanding (Basic)	1,549	1,548	1,418	1,312	1,301
Shares Outstanding (Diluted)	1,562	1,560	1,427	1,313	1,301
Shares Change	0.13%	9.32%	8.68%	0.92%	2.68%
EPS (Basic)	3.84	2.12	0.08	2.44	1.03
EPS (Diluted)	3.81	2.11	0.08	2.44	1.03
EPS Growth	80.57%	2537.50%	-96.72%	136.89%	-39.41%
Free Cash Flow	6,567	7,237	3,763	2,193	509
Free Cash Flow Per Share	4.20	4.64	2.64	1.67	0.39
Gross Margin	81.95%	72.06%	66.76%	80.09%	79.82%
Operating Margin	17.88%	8.47%	2.82%	19.39%	11.99%
Profit Margin	13.00%	7.41%	0.30%	12.01%	5.47%
Free Cash Flow Margin	14.33%	16.32%	10.06%	8.24%	2.09%
Effective Tax Rate	13.60%	-31.67%	-	19.71%	20.74%
EBITDA	13,911	9,327	7,565	8,371	7,016
EBITDA Margin	30.37%	21.03%	20.22%	31.45%	28.77%
Depreciation & Amortization	4,934	5,480	6,530	3,149	3,762
EBIT	8,977	3,847	1,035	5,222	3,254
EBIT Margin	19.60%	8.67%	2.77%	19.62%	13.34%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.